Corrected: Prime Medicine partners with Versant-backed biotech to develop safer stem cell transplants

Lei Lei Wu

News Reporter

Prime Medicine and Cimeio Therapeutics are partnering to develop gene-edited stem cell treatments for two kinds of bone marrow cancers and other potential genetic diseases …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Corrected: Prime Medicine partners with Versant-backed biotech to develop safer stem cell transplants

Lei Lei Wu

News Reporter

Sign up to read this article for free.

Director Oligonucleotide R&D

Bachem

Bubendorf, BL, Switzerland

Bluebird bio to sell to investment funds after struggling to make money from gene therapies

CBER's deputy director departs as staff shakeup continues

Eli Lilly stockpiles $548M of oral weight loss drug ahead of launch

Will CRISPR matter?

FDA approves first drug to treat ultra-rare lipid storage disease

Trusted protection: Why the current meningococcal vaccination schedule shouldn’t change without strong evidence

Cor­rect­ed: Prime Med­i­cine part­ners with Ver­sant-backed biotech to de­vel­op safer stem cell trans­plants

News Reporter

Sign up to read this article for free.

Bachem

Bubendorf, BL, Switzerland

Corrected: Prime Medicine partners with Versant-backed biotech to develop safer stem cell transplants